Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
1(8%)
Results Posted
20%(2 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_3
6
46%
Ph phase_1
1
8%
Ph not_applicable
6
46%

Phase Distribution

1

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 3Large-scale testing
6(46.2%)
N/ANon-phased studies
6(46.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(10)
Terminated(1)
Other(1)

Detailed Status

Completed10
Active, not recruiting1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
90.9%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (7.7%)
Phase 36 (46.2%)
N/A6 (46.2%)

Trials by Status

active_not_recruiting18%
completed1077%
unknown18%
terminated18%

Recent Activity

1 active trials
Showing 5 of 13
active_not_recruitingphase_3

An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM

NCT05994742
completedphase_3

The Treatment of Tuberculosis in HIV-Infected Patients

NCT00001033
completednot_applicable

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection

NCT00000959
completednot_applicable

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

NCT00000796
completednot_applicable

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

NCT00000636
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT05994742Phase 3

An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM

Active Not Recruiting
NCT00001033Phase 3

The Treatment of Tuberculosis in HIV-Infected Patients

Completed
NCT00000959Not Applicable

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection

Completed
NCT00000796Not Applicable

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Completed
NCT00000636Not Applicable

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Completed
NCT00000638Not Applicable

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Completed
NCT00296036Phase 3

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Completed
NCT00486213Phase 3

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Terminated
NCT00559858Phase 3

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer

Unknown
NCT00245050Phase 3

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

Completed
NCT01230359Not Applicable

Early Nutritional Intervention in Patients With Autism Spectrum Disorders

Completed
NCT00000950Not Applicable

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Completed
NCT00000778Phase 1

A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13